Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 859.12% | 410.40% | 114.82% | 108.22% | 63.80% |
| Total Depreciation and Amortization | 3.77% | 5.04% | 4.41% | 2.16% | -7.05% |
| Total Amortization of Deferred Charges | 62.79% | 47.36% | -31.65% | -39.66% | -43.28% |
| Total Other Non-Cash Items | 140.59% | 55.61% | -64.37% | -40.40% | -18.54% |
| Change in Net Operating Assets | 37.40% | 305.16% | -208.80% | 2.55% | 9.33% |
| Cash from Operations | 257.23% | 311.97% | 17.97% | 35.30% | 19.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -80.58% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -52.84% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -42,757.14% | -1,349.28% |
| Cash from Investing | 136.02% | 164.73% | 167.47% | -7,644.44% | -256.99% |
| Total Debt Issued | -- | -- | -- | -90.60% | 98.01% |
| Total Debt Repaid | 96.00% | -677.01% | 44.00% | -158.43% | 82.81% |
| Issuance of Common Stock | -62.88% | -64.91% | -82.19% | -86.32% | -56.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -5,309.43% | -9,533.33% | -- | 33.75% | 33.75% |
| Total Dividends Paid | -- | -- | -- | 100.00% | 100.00% |
| Other Financing Activities | -89.52% | -47.45% | 643.59% | 691.30% | -35.37% |
| Cash from Financing | -107.66% | -102.20% | 9.63% | 10.27% | 2.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,697.07% | 2,347.22% | 188.74% | 291.79% | 75.72% |